Tiotepa Seacross

Medicinal product

(Invented) name

Tiotepa Seacross

Active substance (s)

Tiotepa

Strength

15 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01AC01, Thiotepa

Marketing authorisation holder

UAB PharmaDIA, Lietuva

Date of authorisation

2025-09-30

Date of renewal

Documents

2911_Tiotepa Seacross 15mg_milt_inf_tirp_konc_PZ_2025-09-30.docx

2911_2912_Tiotepa Seacross 15mg_100mg_milt_inf_tirp_konc_PL_2025-09-30.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Tiotepa	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118827	104934	1104934	flakonas	N1		Receptinis	LT/L/25/2911/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-09-30	Registruotas